| URL | https://www.biopharmadive.com/news/eli-lilly-nexus |
| Source | biopharmadive.com |
| Date Published | 04/19/2024 |
| Author Name | Delilah Alvarado |
| Company/Division name | Eli Lilly |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 100 |
| City reshored to: | Pleasant Prairie |
| State(s) reshored to: | WI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | injectable medicines |
| What domestic positive factors made reshoring more attractive? | Under-utilized capacity |